Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from Operating activities
Net loss	$ (12,123,907)	$ (3,640,988)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	969	0
Stock-based compensation	6,590,576	946,958
Fair value of common stock to consultants	669,700	0
Change in fair value of share liability	109,040	2,903
Change in right-of-use lease asset	49,173	51,624
Changes in operating assets and liabilities:
Deferred offering costs	0	(547,373)
Prepaid expenses and other current assets	132,677	(337,612)
Other noncurrent assets	(48,812)	(131,408)
Accounts payable	(298,663)	763,695
Accrued expenses	712,368	935,039
Deferred revenue	882,000	0
Lease liability	(30,292)	(120,697)
Net cash used in operating activities	(3,355,171)	(2,077,859)
Cash flows from investing activities
Purchases of property and equipment	(1,190,157)	(3,570,632)
Net cash used in investing activities	(1,190,157)	(3,570,632)
Cash flows from financing Activities
Proceeds from issuance of common stock	5,000,000	3,119,560
Common stock issuance costs	(506,390)	(255,965)
Repayment of notes payable	0	(13,046)
Net cash provided by financing activities	4,493,610	2,850,549
Net change in cash	(51,718)	(2,797,942)
Effect of exchange rate changes on cash	(50,617)	275,786
Cash - beginning of period	2,389,140	2,953,721
Cash - end of period	2,286,805	431,565
Supplemental disclosures of non-cash investing and financing activities:
Settlement of liabilities with related party	626,223	0
Share liability for non-cash issuance costs	0	124,782
Purchase of property and equipment included in accounts payable	0	332,879
Settlement of share liability	$ 776,695	$ 0